Українська English

ISSN 2522-9028 (Print)
ISSN 2522-9036 (Online)

Fiziologichnyi Zhurnal

is a scientific journal issued by the

Bogomoletz Institute of Physiology
National Academy of Sciences of Ukraine

Editor-in-chief: V.F. Sagach

The journal was founded in 1955 as
1955 – 1977 "Fiziolohichnyi zhurnal" (ISSN 0015 – 3311)
1978 – 1993 "Fiziologicheskii zhurnal" (ISSN 0201 – 8489)
1994 – 2016 "Fiziolohichnyi zhurnal" (ISSN 0201 – 8489)
2017 – "Fiziolohichnyi zhurnal" (ISSN 2522-9028)

Fiziol. Zh. 2022; 68(5): 33-44


T.B.Synelnyk1, O.O.Kravchenko1, O.S. Kostiuk1, O.M.Savchuk1, S.A. Sukhodolia2, L.I. Ostapchenko1

  1. Taras Shevchenko National University of Kyiv, Educational and Scientific Centre “Institute of Biology and Medicine”, Ukraine
  2. National Pirogov Memorial Medical University of Vinnytsya, Ukraine


The content of the plasminogen activation system components (plasminogen, plasminogen tissue activator, and its inhibitor PAI-1) was investigated as well as the concentration of thrombomodulin, protein C, matrix metalproteinases (MMP -1, -2, -3, -8, -9, -10) and their inhibitor TIMP, growth factors content (such as transforming growth factor-β1, insulin-like growth factor-1, fibroblasts growth factor-2) and cytokine profile (interleukines IL-1β, -4, -6, -8, -10, tumor necrosis factor, interferon-γ in patients with chronic pancreatitis (CP) and pancreatic cancer (PC) were established. Khmelnitsky Regional Clinical Hospital patients aged 28-89 were selected for this study: 20 people with chronic pancreatitis (group CP); 20 people with pancreatic cancer (group PC); 20 conditionally healthy persons (control). Blood plasma samples and pancreatic tissue homogenates were obtained from all the patients. The studied indicators’ content in the experimental materials was determined by the enzyme-linked immunosorbent assay using appropriate antibodies. At the level of systemic circulation, a statistically significant increase was found in most of the studied parameters under the CP conditions. However, PC was characterized by an increase of two blood plasma indications only (thrombomodulin and protein C). In contrast, the pancreatic sample tissue examination for both aforementioned pathologies revealed significant changes in the content of most metalloproteinases and cytokines under PC. This indicates the development of metastasis, angiogenesis, and immunomodulation-aimed local biochemical processes in the affected organ.

Keywords: chronic pancreatitis; pancreatic cancer; matrix metalloproteinases; cytokines; plasminogen; growth factors.


  1. Nandy D, Mukhopadhyay D. Growth factor mediated signaling in pancreatic pathogenesis. Cancers. 2011; 3(1):841-71. CrossRef PubMed PubMedCentral
  2. Whitcomb D. Mechanisms of Disease: advances in understanding the mechanisms leading to chronic pancreatitis. Nat Rev Gastroenterol Hepatol. 2004;1:46-52. CrossRef PubMed
  3. Sewpaul1 A, French J, Charnley R. Proteases in pancreatic disease. In: Lendeckel U, Hooper N (eds.). Proteases in Gastrointestinal Tissue. Netherlands: Springer; 2006. p 89-121. CrossRef
  4. Kandikattu HK, Venkateshaiah SU, Mishra A. Chronic pancreatitis and the development of pancreatic cancer. Endocrin Metab Immun Disord Drug Targets. 2020; 20(8):1182-210. CrossRef PubMed PubMedCentral
  5. Gasiorowska A, Talar-Wojnarowska R, Kaczka A, Borkowska A, Czupryniak L, Małecka-Panas E. Subclinical inflammation and endothelial dysfunction in patients with chronic pancreatitis and newly diagnosed pancreatic cancer. Dig Dis Sci. 2016;61:1121-29. CrossRef PubMed PubMedCentral
  6. Fang L, Xu Q, Qian J, Zhou J-Y. Aberrant factors of fibrinolysis and coagulation in pancreatic cancer. OncoTargets Ther. 2021;14:53-65. CrossRef PubMed PubMedCentral
  7. Rybinski B, Franco-Barraza J, Cukierman E. The wound healing, chronic fibrosis, and cancer progression triad. Physiol Genom. 2014;46:223-44. CrossRef PubMed PubMedCentral
  8. Rakashanda S, Rana F, Rafiq S, Masood A, Amin S. Role of proteases in cancer: A review. Biotechnol Molecular Biol Rev. 2012;7(4):90-101. CrossRef
  9. Crowther JR. The ELISA guidebook. Methods Mol Biol. 2000;149:III-IV, 1-413. CrossRef PubMed
  10. Koval TV, Ishchuk TV, Grebinyk DM, Raetska YB, Sokur OV, Savchuk OM, Ostapchenko LI. Matrix metalloproteinase functioning in case of esophagus acid burn. Biomed Res. 2018;29(16):3169-73. CrossRef
  11. Bradford MM. A rаpid and sensitive method for quantities of utilizing the principle of protein binding. Anal Biochem. 1976;86:193-200.
  12. Baluka D, Urbanek T, Lekstan A, Swietochowska E, Wiaderkiewicz R, Kajor M, Jedrzejewska-Szypulka H, Kusnierz K, Lampe P. The role of the tissue plasminogen activator as a prognostic and differentiation factor in patients with pancreatic cancer and chronic pancreatitis. J Physiol Pharmac. 2016; 67(1): 93-101.
  13. Loghmani H, Conway EM. Exploring traditional and nontraditional roles for thrombomodulin. Blood. 2018;132(2):148-58. CrossRef PubMed
  14. Lindahl AK, Boffa MC, Abildgaard U. Increased plasma thrombomodulin in cancer patients. Thromb Haemost. 1993;69(2):112-4. CrossRef PubMed
  15. Włodarczyk B, Borkowska A, Włodarczyk P, MałeckaPanas E, Gąsiorowska A. Insulin-like growth factor 1 and insulin-like growth factor binding protein 2 serum levels as potential biomarkers in differential diagnosis between chronic pancreatitis and pancreatic adenocarcinoma in reference to pancreatic diabetes. Gastroenterology. 2021; 16(1):36-42. CrossRef PubMed PubMedCentral
  16. Meggiato T, Plebani M, Basso D, Panozzo MP, Del Favero G. Serum growth factors in patients with pancreatic cancer. Tumour Biol. 1999;20(2):65-71. CrossRef PubMed
  17. Slapak EJ, Duitman J, Tekin C, Bijlsma MF, Spek CA. Matrix metalloproteases in pancreatic ductal adenocarcinoma: key drivers of disease progression? Biology. 2020;9(4):80. CrossRef PubMed PubMedCentral
  18. Prokopchuk O, Grünwald B, Nitsche U, Jäger C, Prokopchuk OL, Schubert EC, Friess H, Martignoni ME, Krüger A. Elevated systemic levels of the matrix metalloproteinase inhibitor TIMP-1 correlate with clinical markers of cachexia in patients with chronic pancreatitis and pancreatic cancer. BMC Cancer. 2018;18(1):128. CrossRef PubMed PubMedCentral
  19. Ebrahimi B., Tucker SL, Li D, Abbruzzese JL, Kurzrock R. Cytokines in pancreatic carcinoma. Cancer, 2004;101: 2727-36. CrossRef PubMed
  20. van Duijneveldt G, Griffin MDW, Putoczki TL. Emerging roles for the IL-6 family of cytokines in pancreatic cancer. Матеріал надійшов до редакції 12.08.2022 Clin Sci (Lond). 2020;134(16):2091-115. CrossRef PubMed PubMedCentral
  21. Jorgovanovic D, Song M, Wang L, Zhang Y. Roles of IFN-γ in tumor progression and regression: a review. Biomark Res. 2020;8:49. CrossRef PubMed PubMedCentral
  22. Pereira JL, Gomes M, Teixeira AL, Coelho A, Rolfo, C, Araújo A. Potential and importance of metalloproteinases and interleukins in inflammation and metastasization in non-small cell lung cancer. Transl Cancer Res. 2018;7(3):782-95. CrossRef

© National Academy of Sciences of Ukraine, Bogomoletz Institute of Physiology, 2014-2024.